NEW MJ NEWS

AbbVie to Host First-Quarter 2021 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its first-quarter 2021 financial results on Friday, April 30, 2021, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:http://www.prnewswire.com/news-releases/abbvie-to-host-first-quarter-2021-earnings-conference-call-301258997.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$NVLX Gets Exclusive Worldwide License To Use Unique Combine Cell-in-a-Box(R) and Cannabinoid-Based Medicine For Treatment Development

Nuvilex Obtains Exclusive Worldwide License to Develop Disease Treatments That Combine Cell-in-a-Box(R)…

GT Biopharma Inc. (GTBP) Starts FDA Phase 1 Clinical Trial for Myasthenia Gravis Autoimmune Muscular Disease

GT Biopharma, Inc. Starts FDA Phase 1 Clinical Trial for Myasthenia Gravis…

Verano Holdings Corp. (VRNOF) Closing Of Connecticut Pharmaceutical Solutions, Inc and Caring Nature, LLC Transactions

Verano Announces Closing Of Connecticut Pharmaceutical Solutions, Inc and Caring Nature, LLC…

Cara Therapeutics, Inc. (CARA) Announces No Modifications in Trial Size After Completion of Interim Statistical Assessment

Cara Therapeutics Announces No Modifications in Trial Size After Completion of Interim…